Cargando…
Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis
Statin therapy is known to increase blood glucose levels in humans. Statins utilize pregnane X receptor (PXR) and serum/glucocorticoid regulated kinase 2 (SGK2) to activate phosphoenolpyruvate carboxykinase 1 (PEPCK1) and glucose-6-phosphatase (G6Pase) genes, thereby increasing glucose production in...
Autores principales: | Gotoh, Saki, Negishi, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585725/ https://www.ncbi.nlm.nih.gov/pubmed/26392083 http://dx.doi.org/10.1038/srep14076 |
Ejemplares similares
-
Endoplasmic Reticulum Stress Inhibits STAT3-Dependent Suppression of Hepatic Gluconeogenesis via Dephosphorylation and Deacetylation
por: Kimura, Kumi, et al.
Publicado: (2012) -
Regulation of Hepatic Gluconeogenesis by Nuclear Receptor Coactivator 6
por: Oh, Gyun-Sik, et al.
Publicado: (2022) -
Control of hepatic gluconeogenesis by Argonaute2
por: Yan, Xin, et al.
Publicado: (2018) -
Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia
por: Karpale, Mikko, et al.
Publicado: (2022) -
The Nuclear Receptor PXR in Chronic Liver Disease
por: Sayaf, Katia, et al.
Publicado: (2021)